“3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES”, Int. J. Exp. Biol., vol. 2, no. 01, pp. 50–73, Jun. 2024, Accessed: Apr. 30, 2026. [Online]. Available: https://ijeb.online/index.php/IJEB/article/view/23